Table 1. Baseline characteristics.
| Overall | BioIVT (Outpatient) | Baylor (Inpatient) | RWJ (Inpatient) | ||
|---|---|---|---|---|---|
| n = 201 | n = 51 | n = 53 | n = 97 | ||
| Type of Study | Prospective | Prospective | Retrospective | ||
| Age, median (Q1-Q3) | 54 (40.3–67.8) | 53 (41.8–68.8) | 45 (36.3–55.0) | 61 (46.0–71.0) | |
| Gender (Male), N (%) | 106 (52.7) | 20 (39.2) | 23 (43.4) | 63 (64.9) | |
| Race, N (%) | White | 88 (43.8) | 36 (70.6) | 1 (1.9) | 51 (52.6) |
| African American | 35 (17.4) | 1 (2.0) | 19 (35.8) | 15 (15.5) | |
| Other | 78 (38.8) | 14 (27.5) | 32 (60.4) | 31 (32.0) | |
| Infection type, N (%) | Viral | 110 (54.7) | 17 (33.3) | 47 (88.7) | 46 (47.4) |
| Bacterial | 91 (45.3) | 34 (66.7) | 6 (11.3) | 51 (52.6) | |
| WBC (103 cells/μL), median(Q1-Q3) | 7.5 (5.2–11.1) | 6.3 (5.4–8.4) | 6.7 (3.3–9.0) | 9.2 (6.0–14.8) | |
| Granulocyte (%), median(Q1-Q3) | 67.2 (56.5–78.0) | 57.7 (49.0–66.4) | 66.3 (56.2–75.8) | 71.1 (62.2–80.2) | |
| Lymphocyte (%), median(Q1-Q3) | 22.2 (14.6–31.0) | 30.2 (26.5–37.8) | 24.6 (16.5–33.8) | 16.8 (11.8–23.8) | |
| Monocyte (%), median(Q1-Q3) | 8.7 (5.3–13.8) | 9.2 (6.4–14.8) | 7.8 (4.1–12.5) | 9.3 (5.5–14.1) | |